Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases

INTRODUCTION: In the western hemisphere, age-related macular degeneration (AMD) is the leading cause of visual loss in the elderly. Currently approved therapies for AMD include argon laser, photodynamic therapy, and antivascular endothelial growth factor (VEGF) therapy. The index review discusses af...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sophie, Raafay, Akhtar, Abeer, Sepah, Yasir J., Ibrahim, Mohamed, Bittencourt, Millena, Do, Diana V., Nguyen, Quan Dong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare Communications 2012
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3873045/
https://ncbi.nlm.nih.gov/pubmed/24392297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-012-0003-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi